Celldex Therapeutics, Inc. (CLDX)
NASDAQ: CLDX · Real-Time Price · USD
41.71
+0.15 (0.36%)
Aug 7, 2026, 4:00 PM EDT - Market closed
Celldex Therapeutics Employees
Celldex Therapeutics had 198 employees as of December 31, 2025. The number of employees increased by 12 or 6.45% compared to the previous year.
Employees
198
Change (1Y)
12
Growth (1Y)
6.45%
Revenue / Employee
$798
Profits / Employee
-$1,517,924
Market Cap
3.28B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 198 | 12 | 6.45% | 198 | 0 |
| Dec 31, 2024 | 186 | 26 | 16.25% | 186 | 0 |
| Dec 31, 2023 | 160 | 12 | 8.11% | 160 | 0 |
| Dec 31, 2022 | 148 | 14 | 10.45% | 148 | 0 |
| Dec 31, 2021 | 134 | 9 | 7.20% | 132 | 2 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Arcus Biosciences | 601 |
| Arcutis Biotherapeutics | 354 |
| Structure Therapeutics | 233 |
| Alumis | 227 |
| uniQure | 221 |
| Immunome | 206 |
| Disc Medicine | 165 |
| IDEAYA Biosciences | 145 |
CLDX News
- 2 days ago - Celldex price target raised to $46 from $40 at Morgan Stanley - TheFly
- 2 days ago - Celldex price target raised to $53 from $48 at Barclays - TheFly
- 3 days ago - Celldex Therapeutics Earnings release: Q2 2026 - Filings
- 3 days ago - Celldex Therapeutics Quarterly report: Q2 2026 - Filings
- 11 days ago - Celldex price target raised to $72 from $48 at Wells Fargo - TheFly
- 18 days ago - Celldex price target lowered to $61 from $67 at Cantor Fitzgerald - TheFly
- 18 days ago - Celldex price target lowered to $48 from $54 at Wells Fargo - TheFly
- 18 days ago - Celldex price target lowered to $40 from $44 at Morgan Stanley - TheFly